Park J H, Williams B T, Mueller T. "一种奥吡卡朋杂质31的合成方法" [P]. US Patent, US 11440473 B2, 2025-12-19.
发明人郭海燕,高志强,杨光. "Method for the Synthesis of Opicapone impurity 31" [P]. 中国发明专利, 专利号 CN 114547098 B, 授权公告日 2016-07-03.
Davis P L, Schröder R, Anderson J P. "A Process for Preparing High-Purity Opicapone impurity 31" [P]. US Patent, US 10737949 B2, 2022-05-02.
参考文献 Literature
Kumar A, Sharma P, Patel R S. "Development and Validation of an LC-MS/MS Method for the Determination of 奥吡卡朋杂质31 in Pharmaceutical Formulations". Talanta, 2015, 1098, (5), 8716-8733.
O'Brien K, Kennedy M L. "A Stability-Indicating HPLC Method for the Separation and Quantification of 奥吡卡朋杂质31 as an Impurity". Chemosphere, 2017, 2332, 2686-2702.
Hughes D, Roberts J, Thomas A. "Identification and Structural Characterization of a Novel Degradation Product of Opicapone impurity 31 Using HRMS and NMR". Sci. Total Environ., 2017, 2321, (1), 7513-7530.
Kowalski T, Nowak Z. "Forced Degradation Studies to Evaluate 奥吡卡朋杂质31 Profile in Drug Substances According to ICH Guidelines". J. Nat. Prod., 2015, 1145, (10), 729-742.